Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dimitry Lineker"'
Autor:
Jessica Flechtner, Victoria DeVault, Hubert Lam, Julie Arnold, Hanna Starobinets, Stephanie Rinaldi, Charley Hubbard, Osaruese Odeh, Cindy Nguyen, Laura Apolloni, Dimitry Lineker
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/d29e5495f88b4b67880d1c2fc644ce76
Autor:
Hanna S. Starobinets, Victoria L. DeVault, Zoe C. Schmiechen, Ebony A. Miller, Eduardo Cruz, Meagan R. Rollins, Adam L. Burrack, Stephanie J. Rinaldi, Julie Arnold, Emily Tjon, Kyle Gonzalez, Dimitry Lineker, Hubert Lam, Ingunn M. Stromnes, Jessica B. Flechtner
Publikováno v:
Cancer Research. 82:2088-2088
Genocea’s ATLAS platform is an empirical bioassay that uses patient autologous immune cells to identify both true neoantigens and Inhibigens࣪ for inclusion in or exclusion from neoantigen-targeted vaccines and cell therapies, respectively. In ATL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4a5625d3866ef58136b634a8bb8ed5b
https://doi.org/10.1158/1538-7445.am2022-2088
https://doi.org/10.1158/1538-7445.am2022-2088
Autor:
Charley Hubbard, Laura Apolloni, Jessica Flechtner, Julie Arnold, Hanna Starobinets, Dimitry Lineker, Victoria L. DeVault, Cindy Nguyen, Osaruese Odeh, Hubert Lam, Stephanie Rinaldi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundSelecting neoantigens that generate robust anti-tumor T cell responses remains a challenge for cancer immunotherapy design. The ATLASTM platform, a functional recall assay using patient autologous cells, identifies both stimulatory and inhi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4e267b0f9a0cbe5e952ccc6263c4e26
https://doi.org/10.1136/jitc-2021-sitc2021.753
https://doi.org/10.1136/jitc-2021-sitc2021.753